TABLE 1.
Baseline characteristics of the study population
| Baseline characteristic | Intention to treat, N = 992 |
|---|---|
| Age, mean (SD) (y) | 60 (15) |
| Sex (% [n]) | |
| Men | 62 (619) |
| Women | 38 (373) |
| BMI, mean (SD) (kg/m2) | 25.2 (4.61) |
| CKD cause (% [n]) | |
| Hypertension | 28 (276) |
| Diabetes | 39 (384) |
| Autoimmune | 8 (79) |
| Obstructive | 7 (66) |
| Unknown | 12 (121) |
| Other | 7 (66) |
| Medical history (% [n]) | |
| Hypertension | 92 (917) |
| Diabetes | 44 (436) |
| Cardiovascular disease | 37 (364) |
| Comorbidity index (% [n]) | |
| 0 to 3 | 81 (802) |
| 4 to 6 | 17 (170) |
| ≥7 | 2 (20) |
| Karnofsky PS score, median (IQR) | 80 (20) |
| Dialysis vintage, median (IQR) (y) | 3.86 (6.26) |
| PEW diagnosis (% [n]) | 17 (163) |
| Malnutrition inflammation score (% [n]) | |
| Normal | 2 (17) |
| Low | 93 (915) |
| Moderate | 5 (54) |
| Severe | 0.1 (1) |
| Vascular access (% [n]) | |
| AV fistula | 83 (824) |
| Catheter | 15 (144) |
| Graft | 2 (24) |
| No. of treatments/week (% [n]) | |
| 3 | 99 (984) |
| 4 | 0.7 (7) |
| 5 | 0.01 (1) |
| Duration of a dialysis session, median (IQR) (hr) | 4 (0) |
| Dialysate flow, median (IQR) (mL/min) | 500 (0) |
| Blood flow, median (IQR) (mL/min) | 350 (100) |
| Follow‐up time mean (SD) (months) | 10.62 (2.82) |
Abbreviations: BMI, body mass index; CKD, chronic kidney disease; IQR, interquartile range; PEW, protein‐energy wasting; PS, performance scale.